Skip to main content

Proteome to Analyze Cancer Antibodies for Onconome

NEW YORK (GenomeWeb News) — Proteome Sciences said today it will use its ProteoShop services to analyze diagnostic antibodies related to prostate and colon cancer for Onconome.
 
Under the agreement, Proteome Sciences will use its 2-D gel Western blotting technology to characterize Onconome’s antibodies, and will use its 2-D gel electrophoresis and Tandem Mass Tags for further analysis.  
 
Financial terms of the agreement were not released.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.